Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$37.4 - $42.94 $56,698 - $65,097
-1,516 Reduced 0.95%
158,509 $6.02 Million
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $8,301 - $10,286
-238 Reduced 0.15%
160,025 $6.04 Million
Q4 2022

Feb 14, 2023

SELL
$33.8 - $47.06 $49,483 - $68,895
-1,464 Reduced 0.91%
160,263 $6.79 Million
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $26,539 - $314,579
842 Added 0.52%
161,727 $5.2 Million
Q2 2022

Aug 12, 2022

SELL
$26.83 - $38.57 $27,581 - $39,649
-1,028 Reduced 0.63%
160,885 $5.23 Million
Q1 2022

May 13, 2022

BUY
$30.95 - $39.68 $91,797 - $117,690
2,966 Added 1.87%
161,913 $5.86 Million
Q4 2021

Feb 14, 2022

SELL
$35.87 - $47.12 $3.59 Million - $4.71 Million
-100,044 Reduced 38.63%
158,947 $6.29 Million
Q3 2021

Nov 12, 2021

SELL
$41.55 - $48.72 $14.5 Million - $17 Million
-348,055 Reduced 57.34%
258,991 $11.3 Million
Q2 2021

Aug 13, 2021

SELL
$32.88 - $44.57 $4.28 Million - $5.8 Million
-130,215 Reduced 17.66%
607,046 $24.8 Million
Q1 2021

May 17, 2021

BUY
$30.92 - $44.4 $3.1 Million - $4.45 Million
100,177 Added 15.72%
737,261 $24.2 Million
Q4 2020

Feb 16, 2021

BUY
$33.66 - $40.76 $1.12 Million - $1.35 Million
33,214 Added 5.5%
637,084 $25.9 Million
Q3 2020

Nov 13, 2020

BUY
$33.07 - $38.68 $247,892 - $289,945
7,496 Added 1.26%
603,870 $22.1 Million
Q2 2020

Aug 14, 2020

BUY
$20.05 - $33.89 $12 Million - $20.2 Million
596,374 New
596,374 $20.2 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.